Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | APEX nuclease (multifunctional DNA repair enzyme) 1 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.006 | 0.0977 | 0.1562 |
Schistosoma mansoni | hypothetical protein | 0.0069 | 0.1773 | 0.1773 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.006 | 0.0977 | 0.0977 |
Schistosoma mansoni | hypothetical protein | 0.0136 | 0.7627 | 0.7627 |
Schistosoma mansoni | jumonji domain containing protein | 0.006 | 0.0977 | 0.0977 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.012 | 0.6259 | 1 |
Brugia malayi | hypothetical protein | 0.0067 | 0.1569 | 0.1569 |
Brugia malayi | bZIP transcription factor family protein | 0.0085 | 0.3167 | 0.3167 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.006 | 0.0977 | 0.1562 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.006 | 0.0977 | 0.1562 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.2963 | 0.2963 |
Schistosoma mansoni | soluble guanylyl cyclase beta-3 | 0.0136 | 0.7627 | 0.7627 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0085 | 0.3167 | 0.506 |
Schistosoma mansoni | lipoxygenase | 0.0084 | 0.3089 | 0.3089 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0085 | 0.3167 | 0.506 |
Echinococcus granulosus | jun protein | 0.0085 | 0.3167 | 0.506 |
Schistosoma mansoni | jun-related protein | 0.0069 | 0.1773 | 0.1773 |
Schistosoma mansoni | hypothetical protein | 0.0053 | 0.0344 | 0.0344 |
Loa Loa (eye worm) | hypothetical protein | 0.0163 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.005 | 0.0143 | 0.0143 |
Brugia malayi | jmjC domain containing protein | 0.006 | 0.0977 | 0.0977 |
Schistosoma mansoni | soluble guanylate cyclase gcy | 0.0144 | 0.8293 | 0.8293 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.006 | 0.0977 | 0.0977 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.005 | 0.0143 | 0.0143 |
Brugia malayi | jmjC domain containing protein | 0.006 | 0.0977 | 0.0977 |
Loa Loa (eye worm) | guanylyl cyclase/natriuretic peptide receptor | 0.0163 | 1 | 1 |
Schistosoma mansoni | soluble guanylate cyclase gcy | 0.0144 | 0.8293 | 0.8293 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.006 | 0.0977 | 0.1562 |
Schistosoma mansoni | soluble guanylate cyclase gcy | 0.0163 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0143 | 0.0143 |
Echinococcus multilocularis | jun protein | 0.0085 | 0.3167 | 0.506 |
Schistosoma mansoni | soluble guanylate cyclase gcy | 0.0144 | 0.8293 | 0.8293 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.006 | 0.0977 | 0.0977 |
Onchocerca volvulus | 0.0163 | 1 | 1 | |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.012 | 0.6259 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.005 | 0.0143 | 0.0143 |
Schistosoma mansoni | lipoxygenase | 0.012 | 0.6259 | 0.6259 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1889 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 89.1251 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.